Health Canada Announces Fee Changes For Drugs, Devices

Posted 04 April 2012 | By Alexander Gaffney, RAC 

Health Canada released a bevy of guidance documents updating the fee structures for pharmaceutical products and medical devices.

"Health Canada would like to inform sponsors that the following documents have been revised to reflect fees that are current as of 1 April 2012," the agency said in a statement.

The fees for devices and pharmaceutical products reflect a 2% increase "as well as other minor revisions to improve clarity" of various guidance documents.

The agency updated the following documents:

Read more:

Health Canada - Notice on revisions made to guidance documents and forms

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Most Viewed Articles